ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Artificial neural network models for early diagnosis of hepatocellular carcinoma using serum levels of alpha-fetoprotein, alpha-fetoprotein-L3, des-gamma-carboxy prothrombin, and Golgi protein 73

Li, Bo; Li, Boan; Guo, Tongsheng; Sun, Zhiqiang; Li, Xiaohan; Li, Xiaoxi; Chen, Lin; Zhao, Jing; Mao, Yuanli*中国医科大学
Oncotarget2017-10-6DOI: 10.18632/oncotarget.19298
13被引7阅读
引用收藏
分享

摘要

More than 70% of hepatocellular carcinoma (HCC) cases develop as a consequence of liver cirrhosis (LC). Here we have evaluated the diagnostic potential of four serum biomarkers, and developed models for HCC diagnosis and differentiation from LC patients. Serum levels of alpha-fetoprotein (AFP), AFP-L3, des-gamma-carboxy prothrombin (DCP), and Golgi protein 73 (GP73) were analyzed in 114 advanced HCC patients, 81 early stage HCC patients, and 152 LC patients. Multilayer perceptron (MLP) and radial basis RBF) neural networks were used to construct the diagnostic models. Using all stages, HCC diagnostic models had a higher sensitivity (>70%) than the individual serum biomarkers, whereas only early stage HCC diagnostic models had a higher specificity (>80%). The early stage HCC diagnostic models could not be used as HCC screening tools due to their low sensitivity (about 40%). These results suggest that a combination of the two models might be used as a screening tool to distinguish early stage HCC patients from LC patients, thus improving prevention and treatment of HCC.

学科与关键词

关键词
hepatocellular carcinomaartificial neural networkserum tumor biomarker
相关
加载中…
  • Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker
    Chen, Lei*; Ho, David W. Y.; Lee, Nikki P. Y.; Sun, Stella; Lam, Brian; Wong, Kwong-Fai; Yi, Xin; Lau, George K.; Ng, Eddy W. Y.; Poon, Terence C. W.; Lai, Paul B. S.; Cai, Zongwei; Peng, Jirun; Leng, Xisheng; Poon, Ronnie T. P.; Luk, John M.Annals of Surgical Oncology, 2010, 17(9): 2518-2525.被引 37
  • Machine-learning algorithms based on personalized pathways for a novel predictive model for the diagnosis of hepatocellular carcinoma
    Cheng, Binglin; Zhou, Peitao; Chen, Yuhan*BMC BIOINFORMATICS, 2022, 23(1): 248.被引 6
  • Identification and validation of circulating biomarkers for detection of liver cancer with antibody array
    Zhang, Shuangzhe; Gao, Chunhui; Zhou, Qi; Chen, Lipai; Huang, Wei; Huang, Gordon Fan; Tang, Hao; Song, Xuedong; Zhang, Zhuo; Whittaker, Kelly; Chen, Xiaofeng; Huang, Ruo-Pan*Neoplasma, 2023, 70(1): 36-+.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Oncotarget
发表日期
2017-10-06
卷期
第 8 卷, 第 46 期
页码
80521-80530
DOI
10.18632/oncotarget.19298
语言
ENGLISH
成果收录
SCIE
资助标注
Capital Medical Development Project of China [2014-2-5031]; Capital Characteristic Clinical Application Research Project of China [Z171100001017180]

作者

  • L

    Li, Bo (第一作者)

  • L

    Li, Boan

查看全部 9 位作者收起作者
  • G

    Guo, Tongsheng

  • S

    Sun, Zhiqiang

  • L

    Li, Xiaohan

  • L

    Li, Xiaoxi

  • C

    Chen, Lin

  • Z

    Zhao, Jing

  • M

    Mao, Yuanli (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417